AC
WHWK

Aaron Cowen’s Whitehawk Therapeutics WHWK Stock Holding History

Aaron Cowen’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.7M Buy
4,300,000
+600,000
+16% +$2.5M 0.36% 49
2026
Q1 		$12.8M Hold
3,700,000
– – 0.33% 46
2025
Q4 		$8.95M Hold
3,700,000
– – 0.18% 64
2025
Q3 		$7.03M Hold
3,700,000
– – 0.18% 64
2025
Q2 		$6.92M Hold
3,700,000
– – 0.21% 58
2025
Q1 		$6.59M Buy
+3,700,000
New +$9.66M 0.24% 60

Other funds holding WHWK

YF
Yu Fan $108M AUM 137.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $136M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Aaron Cowen's WHWK Position: Q2 2026 in Review

Aaron Cowen increased its Whitehawk Therapeutics (WHWK) stake by 16% in Q2 2026, buying an estimated $2.5M and bringing the position to 4,300,000 shares worth $19.7M. The position accounts for 0.36% of the portfolio, ranked #49.

Aaron Cowen first reported a position in WHWK in Q1 2025 and has held it in 6 quarters since. 78 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

  • Aaron Cowen held 4,300,000 shares of Whitehawk Therapeutics worth $19.7M as of Q2 2026.
  • Aaron Cowen bought 600,000 Whitehawk Therapeutics shares in Q2 2026, an estimated $2.5M.
  • Whitehawk Therapeutics made up 0.36% of Aaron Cowen's portfolio in Q2 2026, its #49 holding.
  • Aaron Cowen first reported a position in Whitehawk Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 78 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on Suvretta Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.